B. Eperjesiova, J. Bogaard, G. Rubin, M. Ehtesham, A. Stone
{"title":"脓毒症和低血容量性休克患者与长期使用去甲肾上腺素、苯肾上腺素、肾上腺素、加压素和/或多巴胺相关的死亡率结局","authors":"B. Eperjesiova, J. Bogaard, G. Rubin, M. Ehtesham, A. Stone","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6698","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":165031,"journal":{"name":"D51. CRITICAL CARE: THE FOUNTAINHEAD - FLUIDS, MONITORING AND MANAGEMENT OF SHOCK","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mortality Outcome of Patients in Septic and Hypovolemic Shock Associated with Prolonged Norepinephrine, Phenylephrine, Epinephrine, Vasopressin and/or Dopamine Use\",\"authors\":\"B. Eperjesiova, J. Bogaard, G. Rubin, M. Ehtesham, A. Stone\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":165031,\"journal\":{\"name\":\"D51. CRITICAL CARE: THE FOUNTAINHEAD - FLUIDS, MONITORING AND MANAGEMENT OF SHOCK\",\"volume\":\"7 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"D51. CRITICAL CARE: THE FOUNTAINHEAD - FLUIDS, MONITORING AND MANAGEMENT OF SHOCK\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6698\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"D51. CRITICAL CARE: THE FOUNTAINHEAD - FLUIDS, MONITORING AND MANAGEMENT OF SHOCK","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6698","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Mortality Outcome of Patients in Septic and Hypovolemic Shock Associated with Prolonged Norepinephrine, Phenylephrine, Epinephrine, Vasopressin and/or Dopamine Use